- Home
- EXOZ vs KRRO Comparison
EXOZ vs KRRO Comparison
Compare EXOZ & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXOZ
- KRRO
- Stock Information
- Founded
- EXOZ 2014
- KRRO 2014
- Country
- EXOZ United States
- KRRO United States
- Employees
- EXOZ N/A
- KRRO N/A
- Industry
- EXOZ
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- EXOZ
- KRRO Health Care
- Exchange
- EXOZ NYSE
- KRRO Nasdaq
- Market Cap
- EXOZ 89.8M
- KRRO 101.4M
- IPO Year
- EXOZ N/A
- KRRO 2019
- Fundamental
- Price
- EXOZ $9.90
- KRRO $12.03
- Analyst Decision
- EXOZ
- KRRO Strong Buy
- Analyst Count
- EXOZ 0
- KRRO 7
- Target Price
- EXOZ N/A
- KRRO $85.67
- AVG Volume (30 Days)
- EXOZ 8.7K
- KRRO 201.2K
- Earning Date
- EXOZ 08-15-2025
- KRRO 08-12-2025
- Dividend Yield
- EXOZ N/A
- KRRO N/A
- EPS Growth
- EXOZ N/A
- KRRO N/A
- EPS
- EXOZ N/A
- KRRO N/A
- Revenue
- EXOZ N/A
- KRRO $4,821,000.00
- Revenue This Year
- EXOZ N/A
- KRRO $65.08
- Revenue Next Year
- EXOZ N/A
- KRRO N/A
- P/E Ratio
- EXOZ N/A
- KRRO N/A
- Revenue Growth
- EXOZ N/A
- KRRO N/A
- 52 Week Low
- EXOZ $8.50
- KRRO $10.29
- 52 Week High
- EXOZ $23.99
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- EXOZ N/A
- KRRO 42.36
- Support Level
- EXOZ N/A
- KRRO $11.52
- Resistance Level
- EXOZ N/A
- KRRO $12.86
- Average True Range (ATR)
- EXOZ 0.00
- KRRO 1.10
- MACD
- EXOZ 0.00
- KRRO -0.03
- Stochastic Oscillator
- EXOZ 0.00
- KRRO 9.53
About EXOZ EXOZYMES INC
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.